The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125869041 12586904 1 I 20151230 20160617 20160725 20160725 EXP US-JNJFOC-20160616830 JANSSEN 23.63 YR A F Y 0.00000 20160725 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125869041 12586904 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y N FIL75015P1;15FO63P1 0 300 MG LYOPHILIZED POWDER
125869041 12586904 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y N FIL75015P1;15FO63P1 0 LYOPHILIZED POWDER
125869041 12586904 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y N FIL75015P1;15FO63P1 0 300 MG LYOPHILIZED POWDER
125869041 12586904 4 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y N FIL75015P1;15FO63P1 103772 300 MG LYOPHILIZED POWDER
125869041 12586904 5 SS BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) U 0 50 MG UNSPECIFIED
125869041 12586904 6 SS BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) U 0 50 MG UNSPECIFIED
125869041 12586904 7 SS ATIVAN LORAZEPAM 1 Intravenous (not otherwise specified) U 0 2 MG UNSPECIFIED
125869041 12586904 8 C TYLENOL ACETAMINOPHEN 1 Oral 0 1000 MG UNSPECIFIED
125869041 12586904 9 C TYLENOL ACETAMINOPHEN 1 Oral 0 1000 MG UNSPECIFIED
125869041 12586904 10 C TYLENOL ACETAMINOPHEN 1 Oral 0 1000 MG UNSPECIFIED
125869041 12586904 11 C SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Unknown 0 40 MG UNSPECIFIED
125869041 12586904 12 C SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Unknown 0 40 MG UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125869041 12586904 1 Crohn's disease
125869041 12586904 2 Crohn's disease
125869041 12586904 3 Crohn's disease
125869041 12586904 4 Crohn's disease
125869041 12586904 5 Premedication
125869041 12586904 6 Premedication
125869041 12586904 7 Product used for unknown indication
125869041 12586904 8 Premedication
125869041 12586904 9 Premedication
125869041 12586904 10 Premedication
125869041 12586904 11 Premedication
125869041 12586904 12 Premedication

Outcome of event

Event ID CASEID OUTC COD
125869041 12586904 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125869041 12586904 Dizziness
125869041 12586904 Flushing
125869041 12586904 Heart rate increased
125869041 12586904 Infusion related reaction
125869041 12586904 Nausea
125869041 12586904 Sensation of foreign body
125869041 12586904 Throat tightness

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125869041 12586904 1 20160120 0
125869041 12586904 3 20151216 0
125869041 12586904 4 20151230 0
125869041 12586904 5 20151230 0
125869041 12586904 6 20160120 0
125869041 12586904 8 20160120 0
125869041 12586904 9 20151230 0
125869041 12586904 10 20151216 0
125869041 12586904 11 20151216 0
125869041 12586904 12 20160120 0